Evidence map›Paper›PMID 41035541›Full record

ArticleJournal of neuroendovascular therapy2025

Adaptive Multimodal Management of Tentorial Dural Arteriovenous Fistula: Cure Achieved via Transvenous Embolization following Transarterial Embolization and Stereotactic Radiosurgery: A Case Report.

Junichi Miyamoto, Hiroyuki Yamamoto, Masataka Nanto

Abstract readCase Reports
In one paragraph

Article in Journal of neuroendovascular therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Junichi MiyamotoDepartment of Neurosurgery Kyoto Saiseikai Hospital, Nagaokakyo, Kyoto, Japan.
Hiroyuki YamamotoDepartment of Neurosurgery Kyoto Saiseikai Hospital, Nagaokakyo, Kyoto, Japan.
Masataka NantoDepartment of Neurosurgery Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Tentorial dural arteriovenous fistula (TDAVF) is a rare subtype of DAVF, and most cases are classified as Borden type III. Due to its aggressive clinical course, therapeutic intervention is frequently required. Treatment modalities include endovascular therapy, direct surgical intervention, and stereotactic radiosurgery. While cases with a simple vascular architecture may be curable with a single treatment modality, a multimodal approach is often needed for those with a complex vascular structure. However, a standardized treatment strategy has yet to be established. Case Presentation: A 63-year-old male patient presented with mild neurological symptoms, but had TDAVF with a large venous varix compressing the brainstem and multiple arterial feeders. Despite undergoing transarterial embolization, direct surgical disconnection, and stereotactic radiosurgery, complete obliteration was not achieved. After shunt flow decreased and the venous varix shrank, transvenous embolization (TVE) was performed, ultimately resulting in the disappearance of TDAVF. Conclusion: The direct surgical interruption of the draining vein has traditionally been performed for TDAVF with a large venous varix. However, when adjacent normal veins preclude the disconnection and an accessible dural sinus is not present, TVE is not the preferred 1st-line option. TVE via the varix or deep veins, combined with flow reduction, may still be a viable alternative for these cases when other treatments are not feasible.

Indexed as

tentorial DAVFtransjugular approachtransvenous embolization

Identifiers

PMID41035541
PMCPMC12483642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.